Cargando…
Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders
Neuromyelitis optica spectrum disorders (NMOSD) are a group of autoimmune inflammatory conditions that primarily target the optic nerves, spinal cord, brainstem, and occasionally the cerebrum. NMOSD is characterized by recurrent attacks of visual, motor, and/or sensory dysfunction that often result...
Autores principales: | Abboud, Hesham, Salazar-Camelo, Andrea, George, Naveen, Planchon, Sarah M., Matiello, Marcelo, Mealy, Maureen A., Goodman, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940781/ https://www.ncbi.nlm.nih.gov/pubmed/34482456 http://dx.doi.org/10.1007/s00415-021-10783-4 |
Ejemplares similares
-
Early indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorder
por: Kessler, Remi A., et al.
Publicado: (2016) -
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder
por: Chavarro, Velina S., et al.
Publicado: (2016) -
B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20
por: Levy, Michael, et al.
Publicado: (2021) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
A pilot safety study of ublituximab, a monoclonal antibody against CD20, in acute relapses of neuromyelitis optica spectrum disorder
por: Mealy, Maureen A., et al.
Publicado: (2019)